awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38352305-083CF881-368E-4BF0-B2A3-0A838A5DF7BC
Q38352305-083CF881-368E-4BF0-B2A3-0A838A5DF7BC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38352305-083CF881-368E-4BF0-B2A3-0A838A5DF7BC
Clinical benefit of sequential use of endocrine therapies for metastatic breast cancer.
P2860
Q38352305-083CF881-368E-4BF0-B2A3-0A838A5DF7BC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38352305-083CF881-368E-4BF0-B2A3-0A838A5DF7BC
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
397eccd9e962761131b8d2435ea4507fb85238e9
P2860
Activity of fulvestrant 500 mg versus anastrozole 1 mg as first-line treatment for advanced breast cancer: results from the FIRST study.